Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection

Annals of Surgical Oncology

Volumn 18, Issue 10, 2011, Pages 2961-2967

  Kosugi, Shin Ichi ^a   Kanda, Tatsuo ^a   Yajima, Kazuhito ^a   Ishikawa, Takashi ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PERIOPERATIVE PERIOD; RISK FACTOR; SURVIVAL RATE; THREE FIELD LYMPH NODE DISSECTION;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80052700965     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1712-5     Document Type: Article

References (19)

1. H Akiyama M Tsurumaru H Udagawa Y Kajiyama 1994 Radical lymph node dissection for cancer of the thoracic esophagus Ann Surg. 220 364 372 8092902 10.1097/00000658-199409000-00012 1:STN:280:DyaK2cznvFyluw%3D%3D
2. H Fujita T Kakegawa H Yamana, et al. 1995 Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy Ann Surg. 222 654 662 7487213 10.1097/00000658-199511000-00008 1:STN:280:DyaK28%2Fms12rsA%3D%3D
3. N Altorki M Kent C Ferrara J Port 2002 Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus Ann Surg. 236 177 183 12170022 10.1097/00000658-200208000-00005 (Pubitemid 34809536)
4. Sobin LH, Wittekind CH. TNM classification of malignant tumors, 6th edn. New York: Wiley-Liss; 2002.
5. S Kosugi R Sasamoto T Kanda A Matsuki K Hatakeyama 2009 Retrospective review of surgery and definitive chemoradiotherapy in patients with squamous cell carcinoma of the thoracic esophagus aged 75 years or older Jpn J Clin Oncol. 39 360 366 19389794 10.1093/jjco/hyp030
6. T Nishimaki T Suzuki S Suzuki S Kuwabara K Hatakeyama 1998 Outcomes of extended radical esophagectomy for thoracic esophageal cancer J Am Coll Surg. 186 306 312 9510261 10.1016/S1072-7515(98)00013-1 1:STN:280:DyaK1c7mvFSrsg%3D%3D (Pubitemid 28124435)
7. National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0. http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ ctcaev3.pdf. Accessed 7 July 2010.
8. Japan Esophageal Society. Japanese classification of esophageal cancer, 10th edn. Tokyo: Kanehara; 2008.
9. H Igaki H Kato Y Tachimori H Sato H Daiko Y Nakanishi 2001 Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection Eur J Cardiothorac Surg. 19 887 893 11404147 10.1016/S1010-7940(01)00701-1 1:STN:280:DC%2BD3Mzjs1aqsg%3D%3D (Pubitemid 32515246)
10. S Nakagawa T Kanda S Kosugi M Ohashi T Suzuki K Hatakeyama 2004 Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy J Am Coll Surg. 198 205 211 14759776 10.1016/j.jamcollsurg.2003.10.005 (Pubitemid 38175235)
11. S Kosugi T Nishimaki T Kanda S Nakagawa M Ohashi K Hatakeyama 2004 Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients World J Surg. 28 680 685 15383868 10.1007/s00268-004-6865-y (Pubitemid 39097125)
12. SM Lagarde JD de Boer FJ ten Kate OR Busch H Obertop JJ van Lanschot 2008 Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence Ann Surg. 247 71 76 18156925 10.1097/SLA.0b013e31815b695e
13. M Watanabe H Kuwano K Araki, et al. 2000 Prognostic factors in patients with submucosal carcinoma of the oesophagus Br J Cancer. 83 609 613 10944600 10.1054/bjoc.2000.1288 1:STN:280:DC%2BD3cvjt1Omtg%3D%3D (Pubitemid 30636301)
14. F Mal T Perniceni H Levard C Denet P Validire B Gayet 2005 Pre-operative predictive factors of early recurrence after resection of adenocarcinoma of the esophagus and cardia Gastroenterol Clin Biol. 29 1275 1278 16518287 10.1016/S0399-8320(05)82221-3 (Pubitemid 43170260)
15. K Takubo K Sasajima K Yamashita Y Tanaka K Fujita 1990 Prognostic significance of intramural metastasis in patients with esophageal carcinoma Cancer. 65 1816 1819 2317758 10.1002/1097-0142(19900415)65:8<1816::AID- CNCR2820650825>3.0.CO;2-L 1:STN:280:DyaK3c7pvFKksA%3D%3D (Pubitemid 20116656)
16. T Nishimaki T Suzuki Y Tanaka K Aizawa K Hatakeyama T Muto 1996 Intramural metastases from thoracic esophageal cancer: local indicators of advanced disease World J Surg. 20 32 37 8588409 10.1007/s002689900006 1:STN:280:DyaK287kvVenuw%3D%3D (Pubitemid 26006194)
17. N Hokamura H Kato Y Tachimori H Watanabe H Yamaguchi Y Nakanishi 2000 Preoperative chemotherapy for esophageal carcinoma with intramural metastasis J Surg Oncol. 75 117 121 11064391 10.1002/1096-9098(200010)75:2<117::AID- JSO8>3.0.CO;2-U 1:CAS:528:DC%2BD3cXot1Wjsb4%3D
18. Igaki H, Kato H, Ando N, et al. A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG 9907). ASCO Meeting Abstracts 26:4510.
19. S Kosugi T Kanda S Nakagawa M Ohashi T Nishimaki K Hatakeyama 2005 Efficacy and toxicity of fluorouracil, doxorubicin, and cisplatin/nedaplatin treatment as neoadjuvant chemotherapy for advanced esophageal carcinoma Scand J Gastroenterol. 40 886 892 16170897 10.1080/00365520510015601 1:CAS:528:DC%2BD2MXhtVWnsrzI (Pubitemid 41117012)